94 related articles for article (PubMed ID: 6687560)
21. m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program.
Weiss RB; Charles LM; Macdonald JS
Cancer Clin Trials; 1980; 3(3):203-9. PubMed ID: 7002337
[TBL] [Abstract][Full Text] [Related]
22. Phase II study of AMSA in patients with metastatic malignant melanoma.
Houghton AM; Camacho F; Wittes R; Young CW
Cancer Treat Rep; 1981; 65(1-2):170-1. PubMed ID: 6894401
[No Abstract] [Full Text] [Related]
23. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
Woodcock TM; Schneider RJ; Young CW
Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
[TBL] [Abstract][Full Text] [Related]
24. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m--anisidine (AMSA) in patients with advanced head and neck cancers.
Ratanatharathorn V; Drelichman A; Sexon-Porte M; Al-Sarraf M
Am J Clin Oncol; 1982 Feb; 5(1):29-32. PubMed ID: 6896258
[TBL] [Abstract][Full Text] [Related]
25. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny N; Lynch G; Wookcock T
Cancer Treat Rep; 1980; 64(10-11):1149-50. PubMed ID: 6893951
[No Abstract] [Full Text] [Related]
26. Amsacrine (AMSA) in the treatment of lymphoma.
Warrell RP
Cancer Treat Rep; 1983 Mar; 67(3):320-1. PubMed ID: 6687561
[No Abstract] [Full Text] [Related]
27. Phase II study of amsacrine gluconate in refractory leukemia.
Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
[TBL] [Abstract][Full Text] [Related]
28. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
Sordillo PP; Magill GB; Gralla RJ; Golbey RB
Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
[No Abstract] [Full Text] [Related]
29. Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
Hilgers RD; Legha SS; Boutselis JG; Hannigan EV; Stephens RL; Tranum BL; Surwit E
Cancer Treat Rep; 1984 Feb; 68(2):443-4. PubMed ID: 6546533
[No Abstract] [Full Text] [Related]
30. [Prospects of new chemotherapies].
Sculier JP; Klastersky J
Rev Med Brux; 1982 Oct; 3(8):519-27. PubMed ID: 6897459
[No Abstract] [Full Text] [Related]
31. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
32. Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase II study.
Amrein PC; Coleman M; Richards F; Bhardwaj S; Kennedy BJ; Haurani FI; Frelick RW; Pastmantier MW; Herschkopf R
Cancer Treat Rep; 1984 Nov; 68(11):1397-8. PubMed ID: 6548660
[No Abstract] [Full Text] [Related]
33. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
Miller LP; Miller DR; Tan CT
Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
[No Abstract] [Full Text] [Related]
34. [Phase I-II studies of a new antineoplastic agent, 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA)].
Horikoshi N; Ogawa M; Inagaki J; Ezaki K; Inoue K; Okabe K; Nagata T; Aiba K; Domyo M
Gan To Kagaku Ryoho; 1982 Feb; 9(2):244-9. PubMed ID: 6897858
[TBL] [Abstract][Full Text] [Related]
35. Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trial.
Omura GA; Bartolucci AA; Lessner HE; Hill GJ
Cancer Treat Rep; 1984 Jun; 68(6):929-30. PubMed ID: 6547369
[No Abstract] [Full Text] [Related]
36. Phase II study of amsacrine in gastric carcinoma: a southwest oncology group study.
Inamasu M; Oishi N; Chen TT; Hicks WJ; O'Bryan RM
Cancer Treat Rep; 1985 May; 69(5):557-8. PubMed ID: 3839167
[No Abstract] [Full Text] [Related]
37. Phase II. Trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in the treatment of advanced non-Hodgkin's lymphoma.
Warrell RP; Straus DJ; Young CW
Cancer Treat Rep; 1980; 64(10-11):1157-8. PubMed ID: 6893952
[TBL] [Abstract][Full Text] [Related]
38. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Ryan DH
Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
Inamasu M; Oishi N; Chen T; Legha S; McCracken J; Balcerzak S; Stephens R; O'Bryan R; Rivkin SE; Costanzi JJ
Cancer Treat Rep; 1984 Nov; 68(11):1411-2. PubMed ID: 6548661
[No Abstract] [Full Text] [Related]
40. [The effect of platinum diamminodichloride (cis-platinum) in the treatment of metastasized testicular teratoma].
Stoter G; Vendrik CP; Struyvenberg A; Pinedo HM
Ned Tijdschr Geneeskd; 1978 Jul; 122(28):1015-20. PubMed ID: 353570
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]